Multi-Level Intervention Addressing Intersectional Stigma to Improve HIV Testing in MSM

多层次干预解决交叉耻辱,改善男男性行为者的艾滋病毒检测

基本信息

  • 批准号:
    10431888
  • 负责人:
  • 金额:
    $ 53.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-05 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY HIV prevalence among men with have sex with men (MSM) in Ghana is at least eight times higher than that of the general population (2%). MSM in Ghana face high levels of stigma due to HIV status (actual or perceived), same-sex behavior, and gender non-conformity. These stigmas are documented barriers to HIV prevention and treatment. In our preliminary work in Ghana (N=137), one-third of MSM had never been tested for HIV. We propose a randomized controlled trial to evaluate the feasibility, acceptability and estimate effect size of a multi-component, multi-level (organizational, interpersonal, and intrapersonal-level) intersectional stigma-reduction intervention to increase HIV testing frequency among MSM in Ghana where HIV, same-sex behavior and gender non-conformity are highly stigmatized. To date, stigma-reduction interventions in Ghana have focused on uni-level targets (e.g., health care facilities (HCFs)) and addressed one type of stigma (e.g., HIV), without engaging the intersectional character of the multiple stigmas that MSM encounter. Our specific aims are: (1) to evaluate the feasibility and acceptability of a novel multi-component, multi-level intervention to address intersectional stigma and (2) to estimate effect size of the intervention for scale up to a definitive efficacy trial. We will combine three theory-based interventions that were previously implemented separately in Ghana for reducing stigma at HCF-level, increasing HIV testing at the peer group-level, and increasing peer social support at the individual-level. We will use the Convergence Framework for combining interventions. The ADAPT-ITT framework guides our approach to enhancing the interventions’ content on intersectional stigma. To achieve these aims we will undergo a systematic adaptation that will refine the individually developed HCF, peer- and individual-level interventions to produce a comprehensive multi-level intersectional stigma reduction intervention. This will consist of focus groups and in-depth interviews with HCF staff and MSM to sharpen content on drivers and manifestations of HIV, same-sex and gender non-conforming stigmas within HCFs and peer groups and how these intersecting stigmas undermine HIV testing. This information will be used to refine the content of the interventions which will then be reviewed by a workgroup of HCF and Ghanaian MSM. The trial involves 8 HCFs, matched on HCF staff size. Matched pairs will each be randomized to have an intervention and a control arm. Before assignment to HCFs, 216 MSM, recruited through Starfish Sampling (combined time-location and peer-referral sampling), will be randomized to receive the intervention or usual care. Each arm of MSM will have members randomized to one of the four clinics per city and asked to stay in the assigned community-clinic pipeline. Using the RCT design, we will formally test the following outcomes: HIV testing at 3 and 6 months, acceptability and feasibility. We will fit multi-level regression models for the predictor variables at the HCF, peer and individual-levels. Based on the study’s findings, we will finalize a protocol to test our intervention in a definitive efficacy trial.
项目总结

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LaRon Earnest Nelson其他文献

96. Associations Between Co-Parenting, Gender Equity Attitudes and Sexual Risk Among Adolescent Mothers and the Biological Fathers of Their Children
  • DOI:
    10.1016/j.jadohealth.2012.10.157
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    LaRon Earnest Nelson;Lance T. McCready;Dionne Gesink;Kathy Anne Asnaran;Dianne Morrison-Beedy;Noah Boakye-Yiadom
  • 通讯作者:
    Noah Boakye-Yiadom

LaRon Earnest Nelson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LaRon Earnest Nelson', 18)}}的其他基金

Multi-Level Intervention Addressing Intersectional Stigma to Improve HIV Testing in MSM
多层次干预解决交叉耻辱,改善男男性行为者的艾滋病毒检测
  • 批准号:
    10213837
  • 财政年份:
    2019
  • 资助金额:
    $ 53.9万
  • 项目类别:
Exploring Stigmas and HIV Diagnosis Delay, Linkage and Retention for MSM in Ghana
探索加纳 MSM 的耻辱感和 HIV 诊断延迟、关联和保留
  • 批准号:
    9063191
  • 财政年份:
    2016
  • 资助金额:
    $ 53.9万
  • 项目类别:
Partner-type Influence on Condom Use in Adolescent Girls
伴侣类型对青春期女孩使用安全套的影响
  • 批准号:
    7304930
  • 财政年份:
    2004
  • 资助金额:
    $ 53.9万
  • 项目类别:
Partner-type Influence on Condom Use in Adolescent Girls
伴侣类型对青春期女孩使用安全套的影响
  • 批准号:
    6990155
  • 财政年份:
    2004
  • 资助金额:
    $ 53.9万
  • 项目类别:
Partner-type Influence on Condom Use in Adolescent Girls
伴侣类型对青春期女孩使用安全套的影响
  • 批准号:
    6989053
  • 财政年份:
    2004
  • 资助金额:
    $ 53.9万
  • 项目类别:
Partner-type Influence on Condom Use in Adolescent Girls
伴侣类型对青春期女孩使用安全套的影响
  • 批准号:
    7150615
  • 财政年份:
    2004
  • 资助金额:
    $ 53.9万
  • 项目类别:
Partner-type Influence on Condom Use in Adolescent Girls
伴侣类型对青春期女孩使用安全套的影响
  • 批准号:
    6790436
  • 财政年份:
    2004
  • 资助金额:
    $ 53.9万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.9万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了